The latest closing stock price for MoonLake Immunotherapeutics as of November 22, 2024 is 54.32.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $4,178 today, roughly 4 times their original investment - a 50.85% compound annual growth rate over 4 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 64.98, which is 19.6% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 37.55, which is 30.9% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 48.67.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $4,178 today, roughly 4 times their original investment - a 50.85% compound annual growth rate over 4 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 64.98, which is 19.6% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 37.55, which is 30.9% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 48.67.